Handel nachbörslich: 2.16 -0.010 -0.46%

Serina Therapeutics Inc (SER)

Überblick Nachrichten Preisverlauf Forum Prognose

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Enterprise value to EBIT forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView

Serina Therapeutics (SER) Stock Forecast and Price Target 2026 $SER - MarketBeat

SER Initiated Coverage by BTIG -- Rating Set to Buy with $8.00 P - GuruFocus

Serina Therapeutics Price Target Announced at $8.00/Share by BTIG - Moomoo

BTIG Initiates Serina Therapeutics(SER.US) With Buy Rating, Announces Target Price $8 - Moomoo

BTIG initiates Serina Therapeutics stock with buy on drug delivery platform - Investing.com Canada

Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program - marketscreener.com

Enterprise value to EBITDA forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView

Enterprise value to revenue forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView

Price to sales forward of Serina Therapeutics, Inc. – AMEX:SER - TradingView

Number of shareholders of Serina Therapeutics, Inc. – AMEX:SER - TradingView

Serina Therapeutics, Inc. Actuals & Estimates (AMEX:SER) - TradingView

SER Forecast — Price Target — Prediction for 2027 - TradingView

2BO Forecast — Price Target — Prediction for 2027 - TradingView

Serina Therapeutics, Inc. Actuals & Estimates (BOATS:SER) - TradingView

Serina Therapeutics Shareholders Approve Expanded Equity and Governance - TipRanks

Serina Therapeutics (NYSE: SER) holders back major share and equity plan increases - Stock Titan

Form 4 Serina Therapeutics Inc For: 22 June By Investing.com - Investing.com South Africa

Serina Therapeutics director Jay Venkatesan buys $1,048 in common stock By Investing.com - Investing.com Australia

Serina Therapeutics director Jay Venkatesan buys $1,048 in common stock - Investing.com

Serina (SER) director converts preferred into common and buys more stock - Stock Titan

Serina Therapeutics (SER) director boosts equity via conversions and new warrants - Stock Titan

Serina Therapeutics (SER) director receives 15,250 stock options at $1.98 - Stock Titan

Serina Therapeutics (SER) director granted 15,250 stock options at $1.98 strike - Stock Titan

Serina Therapeutics (SER) Stock Price, News & Analysis $SER - MarketBeat

Serina Therapeutics Inc (SER) Valuation: PE, PB & Fair Value Analysis - TradingKey

Why Did Serina Therapeutics Stock Rocket 37% After The Bell Today? - MSN

Serina Therapeutics Inc (SER) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Serina Therapeutics Inc (SER) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Serina Therapeutics Inc (SER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Serina Therapeutics Inc (SER) Institutional Confidence - TradingKey

Serina Therapeutics Inc (SER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SER: All proposals, including director elections and share increase, were approved without stockholder questions - TradingView

SER: All eight proposals, including board elections and share increase, were approved without stockholder questions - TradingView

Serina Therapeutics Inc (SER) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Serina Therapeutics Inc (SER) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Serina Therapeutics Inc (SER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

$Serina Therapeutics (SER.US)$ patiently waiting! - Moomoo

Insider Buying: Karen Wilson Acquires Shares of Serina Therapeutics Inc (SER) - GuruFocus

Serina Therapeutics director Karen Wilson buys $17,749 common stock By Investing.com - Investing.com India

Serina Therapeutics director Karen Wilson buys $17,749 common stock - Investing.com UK

Director Karen J. Wilson boosts Serina (SER) stake with 10,100-share purchase - Stock Titan

Serina Therapeutics Inc. (SER) Q1 2026 Earnings: Losses Wider Than Expected as Pre-Revenue Biotech Continues Clinical DevelopmentDownward Estimate Revision - newsline.com

Serina Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Serina Therapeutics (SER) Gains 4% as It Tests Key Resistance at $1.90BPI Bull Confirmed - newsline.com

Serina Therapeutics (SER) Tests Key Support After Modest DeclineSafe Entry Stocks - newsline.com

SER Q1 2026 Earnings: EPS Misses Estimates as Development-Focused Biotechnology Firm Continues Pipeline ProgressGuidance Accuracy Score - dars.gov.et

SER News | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

[EFFECT] Serina Therapeutics, Inc. SEC Filing - Stock Titan

Ähnlich wie SER